Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1

Interventions

Paclitaxel 4Topotecan 3liposomal doxorubicin 2Carboplatin 2irinotecan sucrosofate 1fluzoparib 1anlotinib 1Surgical Procedures, Operative 1Specimen Handling 1Poly A 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Losartan 1Gemcitabine 1Drug Therapy 1Doxorubicin 1Bevacizumab 1Angiogenesis Inhibitors 1Albumin-Bound Paclitaxel 1Adenosine Diphosphate Ribose 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Fallopian Tube Neoplasms × Losartan × Clear all
NCT07265739 2026-05-06

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Massachusetts General Hospital

Phase 2 Not yet recruiting
27 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡